Russom Mulugeta, Jeannetot Daniel Y B, Tesfamariam Sirak, Stricker Bruno H, Verhamme Katia
Eritrean Pharmacovigilance Centre, National Medicines and Food Administration, Ministry of Health, Asmara, Eritrea.
Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, the Netherlands.
Risk Manag Healthc Policy. 2022 Jul 23;15:1407-1419. doi: 10.2147/RMHP.S368315. eCollection 2022.
In Eritrea, a 6-month isoniazid preventive therapy (IPT) was introduced in Eritrea in 2014 to prevent/reduce risk of incident tuberculosis in people living with HIV (PLHIV). The global and local uptake of IPT in newly enrolled PLHIV was reported to be low. Anecdotal reports showed that there was resistance from clinicians against its implementation. This study was therefore conducted to explore the factors that affect implementation of IPT in Eritrea from the perspectives of healthcare professionals.
An exploratory qualitative study that used a framework content analysis using inductive approach was employed. Data were collected from a sample of HIV care clinic prescribers from regional and national referral hospitals through in-depth interviews. Senior program officers were also interviewed as key informants. A conceptual framework model was developed using a root cause analysis.
Overall, five themes and 13 sub-themes emerged from the in-depth interviews with healthcare professionals and key informants. Several multi-level causes/factors related to the healthcare system, HIV control program, healthcare professionals, patients and the product were identified as barriers to the implementation of IPT. Information gap on IPT and fear of isoniazid-induced liver injury were identified as the main reasons for the reluctance in administering IPT. It was observed that healthcare professionals had significant information gap that resulted in rumors and doubts on the benefits and risks of IPT, which ultimately caused reluctance on its implementation. Inadequate planning and operationalization during the introduction of IPT and inadequate laboratory setups were found to be the possible root causes for the aforementioned central problems.
The root causes/factors for the limited implementation of IPT in Eritrea were mainly related to the HIV control program and the healthcare system. Adequate planning, operationalization and capacitation of the existing laboratory setups are recommended for a successful implementation of IPT.
2014年,厄立特里亚引入了为期6个月的异烟肼预防性治疗(IPT),以预防/降低艾滋病毒感染者(PLHIV)发生结核病的风险。据报道,新登记的PLHIV对IPT的全球和本地接受率较低。轶事报告显示,临床医生对其实施存在抵触情绪。因此,本研究旨在从医疗保健专业人员的角度探讨影响厄立特里亚IPT实施的因素。
采用探索性定性研究,运用归纳法进行框架内容分析。通过深入访谈,从地区和国家转诊医院的艾滋病毒护理诊所开处方者样本中收集数据。还采访了高级项目官员作为关键信息提供者。使用根本原因分析开发了一个概念框架模型。
总体而言,通过对医疗保健专业人员和关键信息提供者的深入访谈,出现了五个主题和13个子主题。确定了与医疗保健系统、艾滋病毒控制项目、医疗保健专业人员、患者和产品相关的几个多层次原因/因素,这些是IPT实施的障碍。关于IPT的信息差距和对异烟肼引起肝损伤的恐惧被确定为不愿使用IPT的主要原因。据观察,医疗保健专业人员存在重大信息差距,导致对IPT的益处和风险产生谣言和怀疑,最终导致对其实施的不情愿。发现IPT引入期间规划和实施不足以及实验室设置不足是上述核心问题的可能根本原因。
厄立特里亚IPT实施有限的根本原因/因素主要与艾滋病毒控制项目和医疗保健系统有关。建议进行充分的规划、实施和加强现有实验室设置的能力,以成功实施IPT。